120 related articles for article (PubMed ID: 10448308)
21. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
22. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
23. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1.
Tsuji T; Miyazaki M; Fushimi K; Mihara K; Inoue Y; Ohashi R; Ohtsubo M; Hamazaki K; Furusako S; Namba M
Biochem Biophys Res Commun; 1998 Jan; 242(2):317-21. PubMed ID: 9446792
[TBL] [Abstract][Full Text] [Related]
24. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
25. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
26. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
27. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.
Gong Y; Deng S; Zhang M; Wang G; Minuk GY; Burczynski F
Br J Cancer; 2002 Feb; 86(4):625-9. PubMed ID: 11870547
[TBL] [Abstract][Full Text] [Related]
28. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
[TBL] [Abstract][Full Text] [Related]
29. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
31. Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells.
Oh WJ; Kim WH; Kang KH; Kim TY; Kim MY; Choi KH
Cancer Lett; 1998 Jul; 129(2):215-22. PubMed ID: 9719464
[TBL] [Abstract][Full Text] [Related]
32. A phenylacetate derivative, SCK6, inhibits cell proliferation via G1 cell cycle arrest and apoptosis.
Chan HC; Kuo SC; Huang LJ; Liu CH; Hsu SL
Eur J Pharmacol; 2003 Apr; 467(1-3):31-9. PubMed ID: 12706452
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis and the cell cycle.
Chiarugi V; Magnelli L; Cinelli M; Basi G
Cell Mol Biol Res; 1994; 40(7-8):603-12. PubMed ID: 7787878
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells.
Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E
Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969
[TBL] [Abstract][Full Text] [Related]
35. Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis.
Jin YH; Yim H; Park JH; Lee SK
Biochem Biophys Res Commun; 2003 Jun; 305(4):974-80. PubMed ID: 12767926
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
37. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
[TBL] [Abstract][Full Text] [Related]
38. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Strasberg Rieber M; Welch DR; Miele ME; Rieber M
Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
[TBL] [Abstract][Full Text] [Related]
39. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.
Chen YC; Shen SC; Lee WR; Lin HY; Ko CH; Shih CM; Yang LL
Arch Toxicol; 2002 Jun; 76(5-6):351-9. PubMed ID: 12107653
[TBL] [Abstract][Full Text] [Related]
40. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
